Skip to main content

Massimiliano Camilli, MD

Optimal Stent Design for High Bleeding Risk Patients: Evidence From a Network Meta-Analysis
03/01/2021
Polymer-free (PF) drug-eluting stent (DES) devices have a proven benefit over bare-metal stent (BMS) devices in previous trials. It is unknown, however, whether polymer-based (PB)-DES devices are as safe as PF-DES devices.
Polymer-free (PF) drug-eluting stent (DES) devices have a proven benefit over bare-metal stent (BMS) devices in previous trials. It is unknown, however, whether polymer-based (PB)-DES devices are as safe as PF-DES devices.
Polymer-free (PF) drug-eluting...
03/01/2021
Journal of Invasive Cardiology